U.S. LT; P GT; Invention and Amp; Oacute; N refers to M AMP; EACUTE; all for the local management of chemotherapeutics and amperes; EACUTE; utico a UN a uroterial carcino del tracto superior (UTUC). M AMP; EACUTE; all including the installation of a CAT AMP; EACUTE; TER and BAL AMP; OACUTE; N has a working channel and a BAL AMP; OACUTE; N in UR AMP; EACUTE; TER/PELLVIS Renal A TRAV AMP; EACUTE; S de access URETRAL REPORT AMP; OACUTE; GRA AN AMP; OACUTE; GRAMP; CUT EAT (3) temporary blocking UR AMP; EACUTE; TER; Instilar formula; OACUTE; N liposomal, including chemical agents AMP; EACUTE; usefulness in the working channels of CAT AMP; EACUTE; TER;Formulas and ampoules are allowed; Oacute; N liposomal is allowed to be implanted in UR AMP; EACUTE; TER and/or kidney pelvis long enough for at least part of the formulation and ampoules; Oacute; N liposomal is attached to the European soil wall. In M AMP, EACUTE, all inventions and AMP, OACUTE, N (at least one Poci AMP), OACUTE, N (formula and AMP), OACUTE, N (chemotherapeutic agent and ampere), EACUTE, embedded tools are pasted on the European Union wall during hypnosis and delays of UR AMP, EACUTE, TER and/or PELLVIS Renal. M AMP; EACUTE; all descriptions can be used as ADYUVANTE for other M AMP; EACUTE; all Utuc therapies,For example: ABLACI AMP; OACUTE; N URETROSC AMP; OACUTE; PICA or RECECI AMP; OACUTE; N del tumors. LT; /P GT;<;p>;LA INVENCIÓ;N SE REFIERE A MÉ;TODOS PARA ADMINISTRAR LOCALMENTE UN AGENTE QUIMIOTERAPÉ;UTICO A UN CARCINOMA UROTELIAL DEL TRACTO SUPERIOR (UTUC). LOS MÉ;TODOS CONSISTEN EN COLOCAR UN CATÉ;TER CON BALÓ;N QUE TIENE UN CANAL DE TRABAJO Y UN BALÓ;N EN EL URÉ;TER / PELVIS RENAL A TRAVÉ;S DEL ACCESO URETERAL RETRÓ;GRADO O ANTERÓ;GRADO; INFLAR EL GLOBO DEL CATÉ;TER PARA OBSTRUIR TEMPORALMENTE EL URÉ;TER; INFUNDIR (INSTILAR) UNA FORMULACIÓ;N LIPOSOMAL QUE INCLUYE UN AGENTE QUIMIOTERAPÉ;UTICO EN EL C